Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
How to prevent the potential adverse effects of long-term treatment with proton pump inhibitors (PPIs)?
Paul Moayyedi, MB ChB, PhD:
I do not think that there is any convincing evidence of a long-term risk, so I do not think they really need preventing. But like any medication, it should only be used when it is indicated, and these drugs are often overused. It should be used at the lowest dose that controls patients’ symptoms for the shortest duration that they need.
I often give PPIs on an as-needed basis, and if the patient needs them less and less, they will eventually stop them. That is probably the best way to deprescribe PPIs.
Current management of dyspepsia
A lecture by Dr Paul Moayyedi, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Clinical significance of CMV and other herpes virus infections in ulcerative colitis
This review discusses herpes virus infection in patients with ulcerative colitis (UC), focusing on the prevalence and diagnosis of cytomegalovirus (CMV) infection and prevalence of single or mixed herpes virus infection in addition to CMV. The significance of CMV genotyping in UC is also examined.
Current management of chronic pancreatitis
A lecture by Dr Miroslav Vujasinovic, from Karolinska Institutet, Sweden, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.
Use and misuse of long-term proton pump inhibitors
A lecture by Dr Paul Moayyedi, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.